Immediate Impact
1 by Nobel laureates 1 from Science/Nature 56 standout
Citing Papers
Cross-priming in cancer immunology and immunotherapy
2025 Standout
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
2025 Standout
Works of Gil Awada being referenced
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
2022
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gil Awada | 436 | 148 | 171 | 151 | 58 | 654 | |
| J Dumont | 222 | 94 | 148 | 92 | 35 | 587 | |
| Anna Guidetti | 338 | 91 | 204 | 175 | 61 | 771 | |
| A Faille | 227 | 102 | 273 | 165 | 47 | 737 | |
| Hiroshi Moritake | 176 | 115 | 298 | 99 | 79 | 842 | |
| Xuan Zheng | 261 | 187 | 168 | 90 | 62 | 770 | |
| Jesse McGreivy | 333 | 174 | 331 | 70 | 41 | 687 | |
| Andrea Gombos | 515 | 230 | 297 | 111 | 40 | 772 | |
| Amy Prawira | 321 | 140 | 171 | 93 | 38 | 612 | |
| Mark Cornfeld | 487 | 150 | 288 | 153 | 32 | 823 | |
| Hari Menon | 229 | 182 | 108 | 68 | 69 | 584 |
All Works
Login with ORCID to disown or claim papers
Loading papers...